Log in or Sign up for Free to view tailored content for your specialty!
Oncology News
Colorectal cancer incidence steadily climbing among younger men vs. women
Colorectal cancer incidence has increased since 1988 among men but not women younger than 50 years, suggesting that patient sex should be factored in when determining screening age, data from an Austrian study showed.
Sintilimab improves survival in advanced gastric, gastroesophageal junction cancer
Adding sintilimab to chemotherapy improved survival compared with placebo among patients with unresectable locally advanced or metastatic gastric and gastroesophageal junction adenocarcinoma, phase 3 study results published in JAMA showed.
Log in or Sign up for Free to view tailored content for your specialty!
ACG publishes new guideline for management of alcohol-associated liver disease
A new clinical guideline published in the American Journal of Gastroenterology underscored the need to overcome barriers to alcohol use disorder treatment and expand multidisciplinary care for patients with alcohol-associated liver disease.
Racial, ethnic disparities emerge after neoadjuvant therapy for gastric cancer
There are significant differences in response to treatment and survival outcomes for certain racial and ethnic groups among patients with resected stage II or stage III gastric cancer, study findings published in JAMA Network Open showed.
‘Adding a cup of beans’ to diet boosts gut microbiome diversity in high-risk obesity, CRC
Adding one cup of navy beans to the usual diet of individuals with obesity and a history of colorectal cancer improved gut microbiome diversity and regulated metabolites and markers related to disease, according to research in eBioMedicine.
‘Monumental’ and ‘highly meaningful’ advances across solid tumors highlight ESMO program
MADRID — Remarkable. Highly meaningful. Monumental.
GI cancer screening topped headlines in 2023: Did your patients get the message?
From updates in colorectal cancer screening to developments in screening methods, Healio has been at the forefront of coverage for gastrointestinal cancer in 2023 – but has the important news made its way to your patients?
eAArly DETECT topline data ‘confirm, surpass’ ColoFuture for biomarker accuracy in CRC
Topline findings from the eAArly DETECT trial showed Mainz Biomed’s novel mRNA biomarkers boasted a sensitivity and specificity of 97% for detection of colorectal cancer, and an 82% sensitivity for advanced adenomas detection.
Agent Orange exposure not among risk factors linked to liver cancer in Vietnam veterans
Researchers found no association between Agent Orange exposure and hepatocellular carcinoma among Vietnam veterans, according to study results published in JAMA Network Open.
Binge drinking, genetic predisposition linked to sixfold higher risk for cirrhosis
Heavy binge drinking and high polygenic risk score were associated with a sixfold higher relative excess risk for alcohol-related cirrhosis, with the presence of diabetes mellitus further increasing the risk, researchers reported.
-
Headline News
Rise in alcohol use during pandemic endures as 'an alarming public health issue'
November 14, 20242 min read -
Headline News
AI identified patient messages sent by proxies, but also broke confidentiality
November 14, 20242 min read -
Headline News
Diabetes inequities persist worldwide, especially for low-, middle-income countries
November 14, 20243 min read
-
Headline News
Rise in alcohol use during pandemic endures as 'an alarming public health issue'
November 14, 20242 min read -
Headline News
AI identified patient messages sent by proxies, but also broke confidentiality
November 14, 20242 min read -
Headline News
Diabetes inequities persist worldwide, especially for low-, middle-income countries
November 14, 20243 min read